Nrx Pharmaceuticals Inc (NRXP)

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	36.13% 5.998	4.406	5.808	8.188	9.435
Interest Income/Expense	187.50% 0.23	0.08	0.04	-	-
Operating Income/Loss	36.13% -5.998	-4.406	-5.808	-8.188	-9.435
Nonoperating Income/Loss	816.22% -0.53	0.074	-0.254	-0.529	-1.604
Income/Loss From Continuing Operations Before Tax	50.69% -6.528	-4.332	-6.062	-8.717	-11.04
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	50.69% -6.528	-4.332	-6.062	-8.717	-11.04
Net Income/Loss	50.69% -6.528	-4.332	-6.062	-8.717	-11.04
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	437.29% 8.8523	1.6476	81.95	73.22	67.45
Diluted Average Shares	8.8523	-	81.95	73.22	67.45
Basic Earnings Per Share	1,380% -0.74	-0.05	-0.07	-0.12	-0.16
Diluted Earnings Per Share	-0.74	-	-0.07	-0.12	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-